Rokshaw Laboratories can today announce the launch of our second medical cannabis flower product, manufactured in our MHRA approved manufacturing facility in Sunderland.
After responding to clinical and patient feedback, Rokshaw can now manufacture a new strain of medical cannabis flower giving another option that can be considered for prescription by a specialist prescriber.
In addition to our current full spectrum oil range, Rokshaw is now meeting the growing patient demand for a high quality and reliable range of UK manufactured medical cannabis flower, with varying levels of THC & CBD content.
As part of the EMMAC Life Sciences Group, we are able to import raw material through our integrated supply chain to offer a range of high quality, UK manufactured medical cannabis, available in a variety of different strengths and formulations of THC and CBD.
With our in-house state-of-the-art UK MHRA approved manufacturing facility, along with a vastly experienced team and a comprehensive quality management system, Rokshaw provides pharmaceutical grade product quality at a more affordable price than ever before.
We are already a trusted manufacturer of Specials for more than 2,600 pharmacies, hospitals and dispensing doctors across the UK, adding our range of medical cannabis to our vast number of formulations manufactured on-site.
Jonathan Hodgson, CEO of Rokshaw Laboratories: “We are very excited to launch our second medical cannabis flower product, in addition to our current range. We are always listening and adapting to market feedback, allowing us to deliver medicines with different profiles and characteristics with the aim of making a difference to patients in the UK. As we grow in the medical cannabis field, our vision is to deliver a full range of products that are of the highest quality, affordable and suited to the needs of patients”
Richard Hodgson, Managing Director of Rokshaw Laboratories: ” Patients and healthcare professionals across the UK are looking for an affordable and reliable supply of medical cannabis treatment, therefore we are delighted to now extend our range of medical cannabis flower, manufactured in our state of the art facility. We believe that this is an important moment for the industry, as clinicians are now able to offer more high quality UK manufactured treatment to their patients”
If you are an interested patient, please visit CBPM Access